Trupanion (NASDAQ:TRUP) Given New $41.00 Price Target at Stifel Nicolaus

Trupanion (NASDAQ:TRUP) had its price target cut by equities researchers at Stifel Nicolaus from $44.00 to $41.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the financial services provider’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of 11.95% from the company’s current price.

A number of other equities analysts have also commented on TRUP. Northland Securities boosted their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Piper Sandler cut their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $44.00.

Trupanion Stock Down 22.9 %

TRUP stock traded down $10.89 during trading on Thursday, reaching $36.63. The stock had a trading volume of 1,690,084 shares, compared to its average volume of 544,078. Trupanion has a 1-year low of $19.69 and a 1-year high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $1.55 billion, a P/E ratio of -114.45, a PEG ratio of 8.49 and a beta of 1.60. The firm has a fifty day moving average price of $48.40 and a 200 day moving average price of $47.97.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. On average, equities analysts anticipate that Trupanion will post -0.2 earnings per share for the current year.

Insider Activity

In related news, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00. Following the sale, the senior vice president now owns 24,708 shares in the company, valued at $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 14,681 shares of company stock worth $785,194. 5.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Trupanion

Several institutional investors and hedge funds have recently bought and sold shares of TRUP. Fernwood Investment Management LLC raised its stake in Trupanion by 33.3% during the third quarter. Fernwood Investment Management LLC now owns 20,000 shares of the financial services provider’s stock worth $840,000 after acquiring an additional 5,000 shares during the period. Hanseatic Management Services Inc. bought a new position in Trupanion in the 3rd quarter worth about $538,000. Sigma Planning Corp bought a new position in Trupanion in the 3rd quarter worth about $336,000. Entropy Technologies LP bought a new position in Trupanion in the 3rd quarter worth about $202,000. Finally, GSA Capital Partners LLP grew its position in Trupanion by 51.3% in the 3rd quarter. GSA Capital Partners LLP now owns 10,487 shares of the financial services provider’s stock worth $440,000 after purchasing an additional 3,554 shares during the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.